CompletedNot Applicable

Treatment Patterns and Treatment Outcomes for Acromegaly

United States520 participantsStarted 2016-12

Plain-language summary

This is a human, prospective and retrospective, single-center study of patients who have undergone treatment for acromegaly in New York City since 1981. The project will characterize, among other factors, the treatment methods received by patients, who administered the treatments and the success of this therapy in terms of biochemical control.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult males and females. * Ages 18 and over. * Presenting to the PI or one of the sub-investigators for evaluation of acromegaly. * Must be an Acromegaly subject that have undergone Pituitary surgery with Dr. Bruce or Dr. Post or Present it to principal investigator Dr. Pamela Freda at the Neuroendocrine Unit at Columbia University Medical Center for evaluation of Acromegaly. Exclusion Criteria: * Subjects who are unwilling to comply with the procedures outlined in the study. * Subjects who do not have the ability to fully comprehend the nature of the study, to follow instructions, and/or cooperate with study procedures. * Not being treated for acromegaly either by Dr. Bruce, Dr. Post or Dr. Freda. * Are unwilling to provide informed consent to participate in the study.

What they're measuring

Percentage of patients that have received surgery as first line therapy

Timeframe: At 5 years of therapy

Trial details

NCT IDNCT03043586

SponsorColumbia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Acromegaly trials